M-m-r II vaccine vials
Ended Awarded Last action
- Contract number
- SPE2DR26FW4BA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,964
Award facts
- Contract value 100% obligated
- $9,963.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,963.87 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary pharmaceutical supply vehicle enables delivery of a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The M-M-R II vaccine order reflects the company's role in supplying essential immunization products and medical commodities across multiple therapeutic domains. As a major healthcare solutions provider competing on a full and open basis, AmerisourceBergen maintains extensive federal contract experience delivering both brand-name and generic medications, specialty pharmaceuticals, and critical medical supplies to government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FW4BA?
SPE2DR26FW4BA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FW4BA worth?
The government has obligated $9,964 on SPE2DR26FW4BA.
Is contract SPE2DR26FW4BA an order under another contract?
Yes. SPE2DR26FW4BA is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW4BA competed?
The extent of competition for SPE2DR26FW4BA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award